| P50 | author | Jaume Aguero | Q48833131 |
| | Lauren Fish | Q60057100 |
| P2093 | author name string | Daniel G Anderson | |
| | Kiyotake Ishikawa | |
| | Roger J Hajjar | |
| | Kevin D Costa | |
| | Dongtak Jeong | |
| | Ahmed A Eltoukhy | |
| | Kenneth Fish | |
| | Elisa Yaniz-Galende | |
| | Lisa Tilemann | |
| | Lifan Liang | |
| | Krisztina Zsebo | |
| | Changwon Kho | |
| P2860 | cites work | Epidemiology and risk profile of heart failure | Q24630778 |
| | Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice | Q28257864 |
| | c-kit is required for cardiomyocyte terminal differentiation | Q28595050 |
| | Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial | Q29620043 |
| | RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial | Q29620044 |
| | Mobilized bone marrow cells repair the infarcted heart, improving function and survival | Q31002195 |
| | Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease. | Q34178870 |
| | Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction. | Q34479264 |
| | Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines | Q34698821 |
| | Gene transfer for ischemic heart failure in a preclinical model | Q35392483 |
| | Assessing left ventricular systolic dysfunction after myocardial infarction: are ejection fraction and dP/dt(max) complementary or redundant? | Q35900886 |
| | Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers | Q36193136 |
| | Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance | Q36252910 |
| | Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction | Q36630155 |
| | Stem cell factor gene transfer promotes cardiac repair after myocardial infarction via in situ recruitment and expansion of c-kit+ cells. | Q36837256 |
| | Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function | Q36838880 |
| | The paracrine effect: pivotal mechanism in cell-based cardiac repair | Q37766123 |
| | Direct injection of kit ligand-2 lentivirus improves cardiac repair and rescues mice post-myocardial infarction | Q39503444 |
| | Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit + bone marrow-derived stem cells | Q40153856 |
| | Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised cl | Q40525372 |
| | Neonatal transfer of membrane-bound stem cell factor improves survival and heart function in aged mice after myocardial ischemia. | Q44901261 |
| | Global longitudinal strain measured by two-dimensional speckle tracking echocardiography is closely related to myocardial infarct size in chronic ischaemic heart disease. | Q47288364 |
| | Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells | Q47820046 |
| | Little evidence for developmental plasticity of adult hematopoietic stem cells | Q48491467 |
| | Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factor. | Q48943611 |
| | Repeated and targeted transfer of angiogenic plasmids into the infarcted rat heart via ultrasound targeted microbubble destruction enhances cardiac repair. | Q53278662 |
| | Mesenchymal stem cells engineered to overexpress stem cell factor improve cardiac function but have malignant potential. | Q53315756 |
| | Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts | Q59064540 |
| | Comparison of measures of left ventricular contractile performance derived from pressure-volume loops in conscious dogs | Q69778152 |
| | Position of the American Heart Association on research animal use | Q70058604 |
| | Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction | Q82644908 |
| P433 | issue | 1 | |
| P304 | page(s) | 167-174 | |
| P577 | publication date | 2014-10-23 | |
| P1433 | published in | Circulation: Heart Failure | Q2865806 |
| P1476 | title | Stem cell factor gene transfer improves cardiac function after myocardial infarction in swine | |
| P478 | volume | 8 | |